Company news

Pharmacorp Rx Inc. (TSXV:PCRX) news

Pharmacorp Rx Inc. news releases on 6ix. Latest, Oct 1, 2026: PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update

View Pharmacorp Rx Inc. →

Press releases & updates

PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update

October 1, 2026

PharmaCorp Rx Inc. Announces Board and Committee Changes

August 27, 2026

PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results

August 20, 2026

PharmaCorp Closes Previously Announced Western Canada Pharmacy Acquisition and Announces Two Additional Definitive Agreements

August 18, 2026

PharmaCorp Closes Previously Announced Ontario Pharmacy Acquisition and Provides Update

July 31, 2026

PHARMACORP ANNOUNCES CLOSING OF C$11.5 MILLION BOUGHT DEAL PUBLIC OFFERING

July 14, 2026

PHARMACORP ANNOUNCES C$10 MILLION BOUGHT DEAL PUBLIC OFFERING

July 7, 2026

PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update

July 6, 2026

PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy

June 29, 2026

PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results

June 1, 2026

PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario

May 25, 2026

PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada

May 1, 2026

PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update

April 30, 2026

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 28, 2026

PharmaCorp Announces Investor Relations Agreement

April 13, 2026

PharmaCorp Rx Inc. To Present At The 2026 Bloom Burton & Co. Healthcare Investor Conference

April 2, 2026

PharmaCorp Announces Grant of Stock Options

March 4, 2026

PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada

December 11, 2025

PharmaCorp Announces Executive Transition and New Director of Business Development

November 27, 2025

Pharmacorp Rx Inc. Reports Q3 2025 Financial Results

November 27, 2025

PharmaCorp Announces Supplemental Listing of Warrants

November 13, 2025

PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

November 12, 2025

PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering

November 6, 2025

Canadian Investment Regulatory Organization Trade Resumption - PCRX

November 6, 2025

Canadian Investment Regulatory Organization Trading Halt - PCRX

November 5, 2025

PharmaCorp Announces C$15 Million Bought Deal Public Offering

November 5, 2025

PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus

October 17, 2025

PharmaCorp Refiles Q2 2025 Financial Statements

October 10, 2025

PharmaCorp Closes Acquisitions of Three Pharmacies Across Canada

October 2, 2025

PharmaCorp Rx Inc. Files Preliminary Short Form Base Shelf Prospectus

September 29, 2025

PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation

September 8, 2025

PharmaCorp to Acquire Two Pharmacies in Western Canada

September 3, 2025

PharmaCorp Rx Inc. Reports Q2 2025 Financial Results

August 15, 2025

PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative

August 13, 2025

PharmaCorp Completes Acquisition of a Pharmacy in Western Canada

August 7, 2025

PharmaCorp Announces Filing of Annual Information Form

July 31, 2025

PharmaCorp to Acquire Pharmacy in Western Canada

June 26, 2025

PharmaCorp Rx Inc. Reports First Quarter 2025 Results and Announces Non-Binding Letters of Intent to Acquire Four Pharmacies

May 29, 2025

Pharmacorp Completes Acquisition of Pre-1954 Charter Company in Ontario

May 1, 2025

PharmaCorp Files 2024 Year End Audited Financial Statements and MD&A

April 22, 2025

PharmaCorp Rx Inc. Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference

April 14, 2025

Canadian Investment Regulatory Organization Trading Halt - PTN

June 11, 2024

TSX Venture Exchange Stock Maintenance Bulletins

April 21, 2023

IIROC Trading Halt - PTN.P

April 20, 2023

IIROC Trading Resumption - PTN.P

May 17, 2022